Your browser is no longer supported. Please, upgrade your browser.
INMD InMode Ltd. daily Stock Chart
InMode Ltd.
Index- P/E27.85 EPS (ttm)0.82 Insider Own- Shs Outstand29.32M Perf Week24.82%
Market Cap667.91M Forward P/E- EPS next Y- Insider Trans- Shs Float5.00M Perf Month-
Income26.10M PEG1.24 EPS next Q- Inst Own- Short Float- Perf Quarter-
Sales109.80M P/S6.08 EPS this Y165.90% Inst Trans- Short Ratio- Perf Half Y-
Book/sh- P/B- EPS next Y- ROA- Target Price14.05 Perf Year-
Cash/sh2.82 P/C8.07 EPS next 5Y22.50% ROE- 52W Range13.06 - 23.73 Perf YTD67.87%
Dividend- P/FCF17.86 EPS past 5Y2.61% ROI51.30% 52W High-4.00% Beta-
Dividend %- Quick Ratio3.90 Sales past 5Y- Gross Margin85.60% 52W Low74.43% ATR2.00
Employees209 Current Ratio4.20 Sales Q/Q54.60% Oper. Margin- RSI (14)- Volatility10.81% -
OptionableNo Debt/Eq0.00 EPS Q/Q59.00% Profit Margin- Rel Volume0.79 Prev Close22.60
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.35M Price22.78
Recom4.00 SMA2030.40% SMA5030.40% SMA20030.40% Volume1,078,810 Change0.80%
Aug-20-19 04:05PM  InMode Ltd. Announces Exercise of Over-Allotment Option PR Newswire +6.59%
Aug-15-19 01:38PM  Paula Abdul-Backed Medical IPO Goes Straight Up For Second Day Investor's Business Daily +12.31%
Aug-14-19 04:27PM  Why Purple Innovation, Presidio, and InMode Jumped Today Motley Fool +16.07%
10:00AM  Paula Abdul Helps Newly-Public Skin Treatment Firm InMode Soar Bloomberg
Aug-13-19 04:05PM  InMode Reports Second Quarter 2019 Financial Results; Record Quarterly Revenue of $38.8 Million Reflects Growth of 55% Over Prior Year PR Newswire
08:00AM  Paula Abdul Announced as InMode Brand Ambassador PR Newswire
Aug-12-19 04:10PM  InMode Ltd. Announces Closing of Initial Public Offering PR Newswire
Aug-07-19 08:40PM  InMode Ltd. Announces Pricing of Initial Public Offering PR Newswire
03:46PM  Inmode IPO: What You Need To Know Benzinga
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. InMode Ltd. offers its products directly in the United States, Canada, the United Kingdom, Spain, and India, as well as indirectly through third-party distributors internationally. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.